We found that levels of IgG against ApoA-I peptides and HNE-ApoA-I peptides in CAD patients with 30%~70% and >70% stenosis were slightly lower than those in HCs and CAD patients with <30% stenosis (Figure 3A,B). Here, APOA1 is linked to coronary artery disorder.